SlideShare a Scribd company logo
Respiratory Pharmacology
Inhaled Drugs
• Metered Dose Inhalers (MDIs)
– Spacer
• Dry-Powder Inhalers
• Nebulizers
Drugs for Asthma
• Bronchodilators
– Adrenergic Agonists
• Nonspecific adrenergic agonists
• Beta-2 agonists
– Anticholinergics
– Methylxanthines
• Anti-inflammatory
– Steroids
– Cromolyn
– Leukotriene Inhibitors
Adrenergic Agonists
• Older non-selective drugs
– Ephedrine
– Epinephrine (still used for status asthmaticus)
– Isoproteronol
• Newer selective Beta-2 adrenergic Agonist
– Fewer systemic side effects
– Promote bronchodilation
– Suppress lung histamine
– Increase ciliary motility
Adverse Events
• Tachycardia
• Nervousness, Irritability, Tremor
• Angina
• Inhaled preparations: less common
• Oral preparations: More common
– Tachydysrhythmias
• Usually dose related
• May also be related to additives
Beta-2 Pharmacokinetics
• Duration
– Short acting (begin immediately, 3-5 hour dur)
– Long acting (begin 2-30 min, 10-12 hour dur)
• Routes
– Inhaled
– Oral
• Use
– Short acting: PRN for symptoms
– Long acting: Fixed schedule (NOT PRN EVER)
Agents
• Short acting
– Albuterol (Proventil, Ventolin): MDI, neb
– Levalbuterol (Xopenex): neb only
– Bitolterol (Tornalate): neb only
– Pirbuterol (Maxair): neb only
• Long Acting
– Salmeterol (available only in combination)
– Formoterol (Foradil Aerolizer): DPI
• Oral
– Albuterol: Tablets, Extended tabs, syrup
– Terbutaline: Tablets
Dosing
• Albuterol MDI: usually 1-2 puffs Q 4-6 hrs
– Deep exhale
– Inhale and puff
– Hold breath for slow ten count
– Exhale slowly
– Wait one minute before second puff
– Use spacer
• Dry Powder
– Usually one inhalation, not a puff
– One smooth continuous inhalation
Anticholinergics
• Anticholinergics (atropine derivative)
• Approved only for COPD bronchospasm but
used in asthma also
• Reduces bronchospasm and mucus
• Few systemic side effects
Anticholinergics
• Ipratropium (Atrovent)
– Onset 30 minutes; lasts 6 hours
– MDI, Neb
– Combivent MDI: combo with albuterol
– Also available intranasally for allergic
rhinitis
• Tiotropium (Spiriva)
– Newer, lasts longer
– Dry Powder Inhaler (Handi-haler)
Methylxanthines
• Primary actions
– CNS excitation
– Bronchodilation
• Other actions
– Cardiac stimulation
– Vasodilation
– Diuresis
• Usually considered third line
– High side effect profile
– Narrow therapeutic range
Methylxanthines
• Theophylline and Aminophylline
– Oral
– IV (dangerous, usually aminophylline)
– Longer duration
– Metabolized in liver, variable half-life
– Requires periodic blood level monitoring
– Toxicity: NVD, restlessness, dysrhythmias,
seizures
– Interactions: caffeine, Tagamet,
fluoroquinolones, other CNS drugs
Glucocorticoids
• Decrease release of inflammatory mediator
• Decrease infiltration and action of WBCs
• Decrease airway edema
• Decrease airway mucus production
• Increase number of beta-2 receptors
• Increase sensitivity of beta-2 receptors
Glucocorticoids
• Systemic
– Stronger effects
– Action unaffected by lung restriction
– More side effects, esp with long term therapy
• Inhaled
– Localized action
– Fewer side effects: some absorption occurs
– Disease may prevent penetration of drug to
affected areas
Adverse Events
• Inhaled: gargle and use spacer
– Oral candidiasis
– Dysphonia
• General
– Adrenal suppression
– Bone loss: exercise, Vit D, calcium
– Slow growth in children, but not ultimate height
– Increase risk of cataracts and glaucoma
– PUD
Inhaled Corticosteroids
• Fluticasone (Flovent) MDI
– Advair Diskus DPI (combo with salmeterol)
• Flunisolide (Aerobid) MDI
• Budesonide (Pulmicor Turbohaler) DPI,neb
• Beclomethasone QVAR (MDI)
• Triamcinolone (Azmacort) MDI
• Almost all of these also have intranasal
preparations for allergic rhinitis
Mast Cell Stabilizers
• Used for prophylaxis, not acute treatment
– Seasonal allergy
– Exercise induced asthma
– Can be used intranasally for allergic rhinitis
• Stabilizes mast cells
– Prevents release of histamine, inflam
mediators
– Inhibits eosinophils, macrophages
• MDI
– Cromolyn
Leukotriene Modifiers
• Two approaches
– Inhibit leukotriene synthesis
• Zileuton
– Inhibit leukotriene receptors
• Zafirkulast (Accolate)
• Monteleukast (Singulair) (fewest drug interactions);
also works for allergic rhinitis
• ↓inflammation, bronchoconstriction, edema,
mucus, recruitment of eosinophils
Asthma Treatment
• Mild Intermittent
– Albuterol MDI PRN
• Mild persistent
– Add anti-inflammatory
• Moderate Persistent
– Increase dose of anti-inflammatory
– Multiple anti-inflammatory
– Long acting beta-2 agonist
• Severe persistent asthma
– High inhaled steroids, or systemic steroids
COPD Treatment
• Similar to asthma, difference is damage is
progressive and irreversible
– Ipratropium
– O2 in advanced disease
Allergic Rhinits Medications
• Antihistamines
• Intranasal Glucocorticoids
• Intranasal Cromolyn
• Montelukast (Singulair)
• Sympathomimetics (Decongestants)
Decongestants
• Pseudoephedrine
• Phenylephrine Neo-Synephrine (PO & spray)
• Oxymetazoline (Afrin) nasal spray
• Phenylpropanolamine (taken off market)
• Effects
– Vasoconstriction of nasal arteries
– Shrinkage of swollen membranes
– Adverse: tachycardia, ↑BP (caution HTN),
irritability, insomnia, rebound (topical)
Antihistamines
• First Generation: more side effects
– Drowsiness, Dry Mouth, Dry Eyes, Confusion
– Diphenhydramine (Benadryl)
– Chlorpheniramine (Chlortrimetron)
– Hydroxyzine (Atarax)
• Second Generation
– Fexofenadine (Allegra)
– Loratidine (Claritin)
– Desloratidine (Clarinex)
– Cetirizine (Zyrtec)
Cough Suppressants
(Antitussives)
• Opioid
– Codeine and Hydrocodone
– Reduce cough reflex centrally
• Non-opioid
– Dextromethorphan (DM)
• Codeine derivative
• Reduces cough reflex centrally
• Less euphoria, inhibits Cytochrome P-450
– Benzonatate (Tessalon pearls)
• Local anesthetic
• Decreases stomach receptor sensitivity; do not
chew
Expectorants
• Only one is effective: Guaifenasin
– Need higher doses than usally present in OTC
– 100-200mg OTC (q12 hours)
– 600-1200mg RX (q12 hours)
• Mucolytics: thin mucus
– Hypertonic saline & Acetylcysteine
• Both can cause bronchospasm
• Normal saline (inhaled)
– Used to hydrate lung

More Related Content

Similar to 06-respiratory04-pharm.ppt

Lecture of bronchial asthma
Lecture  of bronchial asthmaLecture  of bronchial asthma
Lecture of bronchial asthma
awad Dr.awad
 
Pharmacology of Respiratory Diseases
Pharmacology of Respiratory DiseasesPharmacology of Respiratory Diseases
Pharmacology of Respiratory Diseasesmunaoqal
 
Respiratory pharma.pptx
Respiratory pharma.pptxRespiratory pharma.pptx
Respiratory pharma.pptx
MensurShafie1
 
Pharmacotherapy of asthma
Pharmacotherapy of asthmaPharmacotherapy of asthma
Pharmacotherapy of asthma
Tabindah Hesam
 
Drugs for bronchial asthma
Drugs for bronchial asthmaDrugs for bronchial asthma
Drugs for bronchial asthma
Chintan Doshi
 
drugs, respiratory drugs, .pptx
drugs, respiratory drugs,          .pptxdrugs, respiratory drugs,          .pptx
drugs, respiratory drugs, .pptx
Rajveer71
 
1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt
1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt
1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt
RaosinghRamadoss
 
Brochial asthma drugs
Brochial asthma drugs Brochial asthma drugs
Brochial asthma drugs
mohamed sanooz
 
Asthma and antiasthmatics
Asthma and antiasthmaticsAsthma and antiasthmatics
Asthma and antiasthmaticsDr.Vijay Talla
 
Bronchial ashtma Drugs by Dr Harikrishna
Bronchial ashtma Drugs by Dr HarikrishnaBronchial ashtma Drugs by Dr Harikrishna
Bronchial ashtma Drugs by Dr Harikrishna
Dr Harikrishna Harindran
 
BRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.pptBRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.ppt
BijayaSaha5
 
Asthma and COPD.pptx
Asthma and COPD.pptxAsthma and COPD.pptx
Asthma and COPD.pptx
SmitaMankar2
 
Asthma and COPD med.ppt
Asthma and COPD med.pptAsthma and COPD med.ppt
Asthma and COPD med.ppt
ssuseref3feb
 
3. Asthma-1.pptx
3. Asthma-1.pptx3. Asthma-1.pptx
3. Asthma-1.pptx
SalimMumba
 
recentadvancesinthemanagementofbronchialasthma-161027153903.pdf
recentadvancesinthemanagementofbronchialasthma-161027153903.pdfrecentadvancesinthemanagementofbronchialasthma-161027153903.pdf
recentadvancesinthemanagementofbronchialasthma-161027153903.pdf
shasshankk12345
 
Recent advances in the management of bronchial asthma
Recent advances in the management of bronchial asthmaRecent advances in the management of bronchial asthma
Recent advances in the management of bronchial asthma
Dr Pritam Biswas MBBS,MD,[MRCP]
 
ASTHMA etiology, risk factors, pathophysiology and it's management
ASTHMA etiology, risk factors, pathophysiology and it's managementASTHMA etiology, risk factors, pathophysiology and it's management
ASTHMA etiology, risk factors, pathophysiology and it's management
PoovarasanA5
 
BRONCHIAL ASTHMA
BRONCHIAL ASTHMABRONCHIAL ASTHMA
BRONCHIAL ASTHMA
SMS MEDICAL COLLEGE
 

Similar to 06-respiratory04-pharm.ppt (20)

Lecture of bronchial asthma
Lecture  of bronchial asthmaLecture  of bronchial asthma
Lecture of bronchial asthma
 
Pharmacology of Respiratory Diseases
Pharmacology of Respiratory DiseasesPharmacology of Respiratory Diseases
Pharmacology of Respiratory Diseases
 
Respiratory pharma.pptx
Respiratory pharma.pptxRespiratory pharma.pptx
Respiratory pharma.pptx
 
Pharmacotherapy of asthma
Pharmacotherapy of asthmaPharmacotherapy of asthma
Pharmacotherapy of asthma
 
Drugs for bronchial asthma
Drugs for bronchial asthmaDrugs for bronchial asthma
Drugs for bronchial asthma
 
drugs, respiratory drugs, .pptx
drugs, respiratory drugs,          .pptxdrugs, respiratory drugs,          .pptx
drugs, respiratory drugs, .pptx
 
1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt
1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt
1.Rao_Bronchodilators and Xanthines_AHS_20 Mar 2024.ppt
 
Brochial asthma drugs
Brochial asthma drugs Brochial asthma drugs
Brochial asthma drugs
 
Asthma and antiasthmatics
Asthma and antiasthmaticsAsthma and antiasthmatics
Asthma and antiasthmatics
 
Bronchial ashtma Drugs by Dr Harikrishna
Bronchial ashtma Drugs by Dr HarikrishnaBronchial ashtma Drugs by Dr Harikrishna
Bronchial ashtma Drugs by Dr Harikrishna
 
BRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.pptBRONCHIAL ASTHMA.ppt
BRONCHIAL ASTHMA.ppt
 
Asthma and COPD.pptx
Asthma and COPD.pptxAsthma and COPD.pptx
Asthma and COPD.pptx
 
Asthma and COPD med.ppt
Asthma and COPD med.pptAsthma and COPD med.ppt
Asthma and COPD med.ppt
 
3. Asthma-1.pptx
3. Asthma-1.pptx3. Asthma-1.pptx
3. Asthma-1.pptx
 
recentadvancesinthemanagementofbronchialasthma-161027153903.pdf
recentadvancesinthemanagementofbronchialasthma-161027153903.pdfrecentadvancesinthemanagementofbronchialasthma-161027153903.pdf
recentadvancesinthemanagementofbronchialasthma-161027153903.pdf
 
Recent advances in the management of bronchial asthma
Recent advances in the management of bronchial asthmaRecent advances in the management of bronchial asthma
Recent advances in the management of bronchial asthma
 
REPORT
REPORTREPORT
REPORT
 
report
reportreport
report
 
ASTHMA etiology, risk factors, pathophysiology and it's management
ASTHMA etiology, risk factors, pathophysiology and it's managementASTHMA etiology, risk factors, pathophysiology and it's management
ASTHMA etiology, risk factors, pathophysiology and it's management
 
BRONCHIAL ASTHMA
BRONCHIAL ASTHMABRONCHIAL ASTHMA
BRONCHIAL ASTHMA
 

More from WILLIAMSADU1

HEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
HEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPHEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
HEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
WILLIAMSADU1
 
lecture 1 Course outline of internal medicine
lecture 1 Course outline of internal medicinelecture 1 Course outline of internal medicine
lecture 1 Course outline of internal medicine
WILLIAMSADU1
 
health system management. the second part
health system management. the second parthealth system management. the second part
health system management. the second part
WILLIAMSADU1
 
HEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptx
HEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptxHEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptx
HEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptx
WILLIAMSADU1
 
HEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptx
HEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptxHEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptx
HEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptx
WILLIAMSADU1
 
ABDOMINAL TRAUMA.pptx
ABDOMINAL TRAUMA.pptxABDOMINAL TRAUMA.pptx
ABDOMINAL TRAUMA.pptx
WILLIAMSADU1
 
PMTCT.pptx
PMTCT.pptxPMTCT.pptx
PMTCT.pptx
WILLIAMSADU1
 
WOUNDS AND ULCERS-1.pptx
WOUNDS AND ULCERS-1.pptxWOUNDS AND ULCERS-1.pptx
WOUNDS AND ULCERS-1.pptx
WILLIAMSADU1
 
(_nut)LECTURE_SAM[2].pptx
(_nut)LECTURE_SAM[2].pptx(_nut)LECTURE_SAM[2].pptx
(_nut)LECTURE_SAM[2].pptx
WILLIAMSADU1
 
A presentation on Elephantiasis.pptx
A presentation on Elephantiasis.pptxA presentation on Elephantiasis.pptx
A presentation on Elephantiasis.pptx
WILLIAMSADU1
 
309 NUSING PSYCHIATRY.pptx
309 NUSING PSYCHIATRY.pptx309 NUSING PSYCHIATRY.pptx
309 NUSING PSYCHIATRY.pptx
WILLIAMSADU1
 
38 UTI.ppt
38 UTI.ppt38 UTI.ppt
38 UTI.ppt
WILLIAMSADU1
 
Essential Amino acids.pptx
Essential Amino acids.pptxEssential Amino acids.pptx
Essential Amino acids.pptx
WILLIAMSADU1
 
Human Reproduction.ppt
Human Reproduction.pptHuman Reproduction.ppt
Human Reproduction.ppt
WILLIAMSADU1
 
BIOLOGY SBBS-1.pptx
BIOLOGY SBBS-1.pptxBIOLOGY SBBS-1.pptx
BIOLOGY SBBS-1.pptx
WILLIAMSADU1
 
Enzymes lecture.ppt
Enzymes lecture.pptEnzymes lecture.ppt
Enzymes lecture.ppt
WILLIAMSADU1
 
lecture 6 special senses.ppt
lecture 6 special senses.pptlecture 6 special senses.ppt
lecture 6 special senses.ppt
WILLIAMSADU1
 
MAN N7-LO! GOD IS HERE!.ppt
MAN N7-LO! GOD IS HERE!.pptMAN N7-LO! GOD IS HERE!.ppt
MAN N7-LO! GOD IS HERE!.ppt
WILLIAMSADU1
 
MAN N1-AWAKE MY SOUL.ppt
MAN N1-AWAKE MY SOUL.pptMAN N1-AWAKE MY SOUL.ppt
MAN N1-AWAKE MY SOUL.ppt
WILLIAMSADU1
 
MAN N3- ALL THINGS PRAISE THEE.ppt
MAN N3- ALL THINGS PRAISE THEE.pptMAN N3- ALL THINGS PRAISE THEE.ppt
MAN N3- ALL THINGS PRAISE THEE.ppt
WILLIAMSADU1
 

More from WILLIAMSADU1 (20)

HEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
HEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPHEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
HEALTH PRESENTATION PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPP
 
lecture 1 Course outline of internal medicine
lecture 1 Course outline of internal medicinelecture 1 Course outline of internal medicine
lecture 1 Course outline of internal medicine
 
health system management. the second part
health system management. the second parthealth system management. the second part
health system management. the second part
 
HEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptx
HEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptxHEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptx
HEALTH SYSTEMS MANAGEMENT II UNIT TWO [Autosaved].pptx
 
HEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptx
HEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptxHEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptx
HEALTH SYSTEMS MANAGEMENT II UNIT THREE.pptx
 
ABDOMINAL TRAUMA.pptx
ABDOMINAL TRAUMA.pptxABDOMINAL TRAUMA.pptx
ABDOMINAL TRAUMA.pptx
 
PMTCT.pptx
PMTCT.pptxPMTCT.pptx
PMTCT.pptx
 
WOUNDS AND ULCERS-1.pptx
WOUNDS AND ULCERS-1.pptxWOUNDS AND ULCERS-1.pptx
WOUNDS AND ULCERS-1.pptx
 
(_nut)LECTURE_SAM[2].pptx
(_nut)LECTURE_SAM[2].pptx(_nut)LECTURE_SAM[2].pptx
(_nut)LECTURE_SAM[2].pptx
 
A presentation on Elephantiasis.pptx
A presentation on Elephantiasis.pptxA presentation on Elephantiasis.pptx
A presentation on Elephantiasis.pptx
 
309 NUSING PSYCHIATRY.pptx
309 NUSING PSYCHIATRY.pptx309 NUSING PSYCHIATRY.pptx
309 NUSING PSYCHIATRY.pptx
 
38 UTI.ppt
38 UTI.ppt38 UTI.ppt
38 UTI.ppt
 
Essential Amino acids.pptx
Essential Amino acids.pptxEssential Amino acids.pptx
Essential Amino acids.pptx
 
Human Reproduction.ppt
Human Reproduction.pptHuman Reproduction.ppt
Human Reproduction.ppt
 
BIOLOGY SBBS-1.pptx
BIOLOGY SBBS-1.pptxBIOLOGY SBBS-1.pptx
BIOLOGY SBBS-1.pptx
 
Enzymes lecture.ppt
Enzymes lecture.pptEnzymes lecture.ppt
Enzymes lecture.ppt
 
lecture 6 special senses.ppt
lecture 6 special senses.pptlecture 6 special senses.ppt
lecture 6 special senses.ppt
 
MAN N7-LO! GOD IS HERE!.ppt
MAN N7-LO! GOD IS HERE!.pptMAN N7-LO! GOD IS HERE!.ppt
MAN N7-LO! GOD IS HERE!.ppt
 
MAN N1-AWAKE MY SOUL.ppt
MAN N1-AWAKE MY SOUL.pptMAN N1-AWAKE MY SOUL.ppt
MAN N1-AWAKE MY SOUL.ppt
 
MAN N3- ALL THINGS PRAISE THEE.ppt
MAN N3- ALL THINGS PRAISE THEE.pptMAN N3- ALL THINGS PRAISE THEE.ppt
MAN N3- ALL THINGS PRAISE THEE.ppt
 

Recently uploaded

The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

06-respiratory04-pharm.ppt

  • 2. Inhaled Drugs • Metered Dose Inhalers (MDIs) – Spacer • Dry-Powder Inhalers • Nebulizers
  • 3. Drugs for Asthma • Bronchodilators – Adrenergic Agonists • Nonspecific adrenergic agonists • Beta-2 agonists – Anticholinergics – Methylxanthines • Anti-inflammatory – Steroids – Cromolyn – Leukotriene Inhibitors
  • 4. Adrenergic Agonists • Older non-selective drugs – Ephedrine – Epinephrine (still used for status asthmaticus) – Isoproteronol • Newer selective Beta-2 adrenergic Agonist – Fewer systemic side effects – Promote bronchodilation – Suppress lung histamine – Increase ciliary motility
  • 5. Adverse Events • Tachycardia • Nervousness, Irritability, Tremor • Angina • Inhaled preparations: less common • Oral preparations: More common – Tachydysrhythmias • Usually dose related • May also be related to additives
  • 6. Beta-2 Pharmacokinetics • Duration – Short acting (begin immediately, 3-5 hour dur) – Long acting (begin 2-30 min, 10-12 hour dur) • Routes – Inhaled – Oral • Use – Short acting: PRN for symptoms – Long acting: Fixed schedule (NOT PRN EVER)
  • 7. Agents • Short acting – Albuterol (Proventil, Ventolin): MDI, neb – Levalbuterol (Xopenex): neb only – Bitolterol (Tornalate): neb only – Pirbuterol (Maxair): neb only • Long Acting – Salmeterol (available only in combination) – Formoterol (Foradil Aerolizer): DPI • Oral – Albuterol: Tablets, Extended tabs, syrup – Terbutaline: Tablets
  • 8. Dosing • Albuterol MDI: usually 1-2 puffs Q 4-6 hrs – Deep exhale – Inhale and puff – Hold breath for slow ten count – Exhale slowly – Wait one minute before second puff – Use spacer • Dry Powder – Usually one inhalation, not a puff – One smooth continuous inhalation
  • 9.
  • 10.
  • 11. Anticholinergics • Anticholinergics (atropine derivative) • Approved only for COPD bronchospasm but used in asthma also • Reduces bronchospasm and mucus • Few systemic side effects
  • 12. Anticholinergics • Ipratropium (Atrovent) – Onset 30 minutes; lasts 6 hours – MDI, Neb – Combivent MDI: combo with albuterol – Also available intranasally for allergic rhinitis • Tiotropium (Spiriva) – Newer, lasts longer – Dry Powder Inhaler (Handi-haler)
  • 13. Methylxanthines • Primary actions – CNS excitation – Bronchodilation • Other actions – Cardiac stimulation – Vasodilation – Diuresis • Usually considered third line – High side effect profile – Narrow therapeutic range
  • 14. Methylxanthines • Theophylline and Aminophylline – Oral – IV (dangerous, usually aminophylline) – Longer duration – Metabolized in liver, variable half-life – Requires periodic blood level monitoring – Toxicity: NVD, restlessness, dysrhythmias, seizures – Interactions: caffeine, Tagamet, fluoroquinolones, other CNS drugs
  • 15. Glucocorticoids • Decrease release of inflammatory mediator • Decrease infiltration and action of WBCs • Decrease airway edema • Decrease airway mucus production • Increase number of beta-2 receptors • Increase sensitivity of beta-2 receptors
  • 16. Glucocorticoids • Systemic – Stronger effects – Action unaffected by lung restriction – More side effects, esp with long term therapy • Inhaled – Localized action – Fewer side effects: some absorption occurs – Disease may prevent penetration of drug to affected areas
  • 17. Adverse Events • Inhaled: gargle and use spacer – Oral candidiasis – Dysphonia • General – Adrenal suppression – Bone loss: exercise, Vit D, calcium – Slow growth in children, but not ultimate height – Increase risk of cataracts and glaucoma – PUD
  • 18. Inhaled Corticosteroids • Fluticasone (Flovent) MDI – Advair Diskus DPI (combo with salmeterol) • Flunisolide (Aerobid) MDI • Budesonide (Pulmicor Turbohaler) DPI,neb • Beclomethasone QVAR (MDI) • Triamcinolone (Azmacort) MDI • Almost all of these also have intranasal preparations for allergic rhinitis
  • 19.
  • 20. Mast Cell Stabilizers • Used for prophylaxis, not acute treatment – Seasonal allergy – Exercise induced asthma – Can be used intranasally for allergic rhinitis • Stabilizes mast cells – Prevents release of histamine, inflam mediators – Inhibits eosinophils, macrophages • MDI – Cromolyn
  • 21. Leukotriene Modifiers • Two approaches – Inhibit leukotriene synthesis • Zileuton – Inhibit leukotriene receptors • Zafirkulast (Accolate) • Monteleukast (Singulair) (fewest drug interactions); also works for allergic rhinitis • ↓inflammation, bronchoconstriction, edema, mucus, recruitment of eosinophils
  • 22. Asthma Treatment • Mild Intermittent – Albuterol MDI PRN • Mild persistent – Add anti-inflammatory • Moderate Persistent – Increase dose of anti-inflammatory – Multiple anti-inflammatory – Long acting beta-2 agonist • Severe persistent asthma – High inhaled steroids, or systemic steroids
  • 23. COPD Treatment • Similar to asthma, difference is damage is progressive and irreversible – Ipratropium – O2 in advanced disease
  • 24. Allergic Rhinits Medications • Antihistamines • Intranasal Glucocorticoids • Intranasal Cromolyn • Montelukast (Singulair) • Sympathomimetics (Decongestants)
  • 25. Decongestants • Pseudoephedrine • Phenylephrine Neo-Synephrine (PO & spray) • Oxymetazoline (Afrin) nasal spray • Phenylpropanolamine (taken off market) • Effects – Vasoconstriction of nasal arteries – Shrinkage of swollen membranes – Adverse: tachycardia, ↑BP (caution HTN), irritability, insomnia, rebound (topical)
  • 26. Antihistamines • First Generation: more side effects – Drowsiness, Dry Mouth, Dry Eyes, Confusion – Diphenhydramine (Benadryl) – Chlorpheniramine (Chlortrimetron) – Hydroxyzine (Atarax) • Second Generation – Fexofenadine (Allegra) – Loratidine (Claritin) – Desloratidine (Clarinex) – Cetirizine (Zyrtec)
  • 27. Cough Suppressants (Antitussives) • Opioid – Codeine and Hydrocodone – Reduce cough reflex centrally • Non-opioid – Dextromethorphan (DM) • Codeine derivative • Reduces cough reflex centrally • Less euphoria, inhibits Cytochrome P-450 – Benzonatate (Tessalon pearls) • Local anesthetic • Decreases stomach receptor sensitivity; do not chew
  • 28. Expectorants • Only one is effective: Guaifenasin – Need higher doses than usally present in OTC – 100-200mg OTC (q12 hours) – 600-1200mg RX (q12 hours) • Mucolytics: thin mucus – Hypertonic saline & Acetylcysteine • Both can cause bronchospasm • Normal saline (inhaled) – Used to hydrate lung